Drawing for ECRF+

USPTO serial 97401049

ECRF+

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
UKAOMA, ULOMA JANET
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ECRF+?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Christopher A. Proskey

Christopher A. Proskey BROWNWINICK LAW FIRM666 GRAND AVENUE, SUITE 2000DES MOINES, IA 50309UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035Business services provided to the healthcare industry, namely, evaluation and systemization of testing results for medical data analysis into computer databases; medical data testing assessment services, and patient identification services in the nature of storing and analyzing patient data; medical data testing assessment services for systemization of information into computer databases, clinical trial development services in the nature of management and compilation of computerized databases in the field of clinical trials for business purposes; research study development services in the nature of management and compilation of computerized databases in the field of healthcare for business purposes; standard of care business development services, and data analysis services in the field of healthcare; business services provided to the healthcare industry, namely, the collection, reporting, and analysis of healthcare quality data for business purposes; Collection and analysis of quality clinical and empirical data for a network of health care providers for business purposes; none of the foregoing services in the fields of genetics, genetics testing, or business analytics of genetics testingACTIVE—
042Software as a service (SAAS) services featuring software for use in the collection and analysis of healthcare data and healthcare information; Platform as a service featuring computer software platforms, namely, data application platform to store and analyze patient data in the healthcare industry; computer services, namely, providing computer software as a service (SaaS) featuring software for identifying, collecting, managing, analyzing, segmenting, retrieving, monitoring, maintaining, reporting on, structuring, modeling, forecasting, presenting and displaying healthcare data and healthcare information; computer services, namely, providing platforms as a service (PaaS) featuring computer software for creating web applications, data storage and backup, database management, virtualization, networking, collaboration, information access, customer service and support, cloud computing, data sharing, data security, all in the field of healthcare data and healthcare information; computer services, namely, providing platforms as a service (PaaS) featuring computer software for administration and management of, and distribution and transmission of healthcare data and healthcare information; computer services, namely, providing databases as a service (DBaaS), namely, cloud hosting of computer databases for others and providing online non-downloadable software for database management and data analytics, all in the healthcare industry; computer services, namely, providing data as a service through a customizable software platform for collecting, analyzing, segmenting, integrating, transforming and providing access to healthcare data and healthcare information; computer services, namely, providing data as a service to the healthcare industry through a customizable software platform for collecting, analyzing, segmenting, integrating, transforming and providing access to healthcare data and healthcare information; data as a service (DAAS) services, namely, providing online non-downloadable software for accessing healthcare related data through an electronic computer network; data as a service (DaaS) services, namely, providing online non-downloadable software for use in the collection and analysis of healthcare data and healthcare information; application service provider (ASP) services featuring software for use in the collection and analysis of healthcare data and healthcare information; application service provider featuring non-downloadable application programming interface (API) software for use in the collection and analysis of healthcare data and healthcare information; data as a service (DaaS) services through a customizable software platform for collecting, analyzing, integrating, transforming and providing access to healthcare data and healthcare information; Clinical trial development services, namely, conducting research and clinical trials for others relating to healthcareACTIVE—
044Medical testing services for diagnostic or treatment purposes, namely, evaluation of testing results; Medical information services provided via the Internet, namely, patient identification services; Health assessment services, namely, testing assessment services; Medical analysis services relating to the treatment of patients, namely, treatment selection services for patients, Health assessment services, namely, treatment assessment services; Health assessment services, namely, outcome assessment services; Medical research study development services; Medical information, namely, providing standard of care development services for diagnostic or treatment purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Dec 23, 2024MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 23, 2024ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 21, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 26, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 26, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 6, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 6, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 21, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 5, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 5, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 5, 2023ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Sep 6, 2023GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Sep 6, 2023GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 6, 2023CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 26, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 25, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 25, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 3, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 3, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 3, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 3, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 3, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 3, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 6, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 6, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 6, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 1, 2022DOCKASSIGNED TO EXAMINER—
May 24, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 24, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 24, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 13, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 12, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance